TrialJournal for immunotherapy of cancer2021

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.

Niannian Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.